Business Description
Sedana Medical AB
ISIN : SE0015988373
Total Employee Number:
116Compare
Compare
Traded in other countries / regions
SEDANA.Sweden7D2A.Germany IPO Date
2018-07-20Description
Sedana Medical AB is a Sweden-based medical technology company. It is ais a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care. Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, and Spain. In other parts of Europe, as well as in Asia, Australia, Canada, and South and Central America, the company works with external distributors.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 7.07 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -1.31 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 10.4 | |||||
Beneish M-Score | -2.7 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.7 | |||||
3-Year EBITDA Growth Rate | 11.5 | |||||
3-Year EPS without NRI Growth Rate | 6.8 | |||||
3-Year FCF Growth Rate | 33.3 | |||||
3-Year Book Growth Rate | -4.3 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 22.33 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 92.07 | |||||
9-Day RSI | 81.79 | |||||
14-Day RSI | 71.99 | |||||
3-1 Month Momentum % | -21.91 | |||||
6-1 Month Momentum % | -27.12 | |||||
12-1 Month Momentum % | -50.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.89 | |||||
Quick Ratio | 1.94 | |||||
Cash Ratio | 1.15 | |||||
Days Inventory | 273.37 | |||||
Days Sales Outstanding | 49.74 | |||||
Days Payable | 39.98 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 71.98 | |||||
Operating Margin % | -16.3 | |||||
Net Margin % | -18.33 | |||||
EBITDA Margin % | -2.87 | |||||
FCF Margin % | -37.52 | |||||
OCF Margin % | -5.75 | |||||
ROE % | -3.97 | |||||
ROA % | -3.74 | |||||
ROIC % | -3.72 | |||||
3-Year ROIIC % | 18.11 | |||||
ROC (Joel Greenblatt) % | -92.28 | |||||
ROCE % | -3.5 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 5.16 | |||||
PB Ratio | 1.13 | |||||
Price-to-Tangible-Book | 10.71 | |||||
EV-to-EBIT | -29.27 | |||||
EV-to-Forward-EBIT | -29.03 | |||||
EV-to-EBITDA | -166.45 | |||||
EV-to-Forward-EBITDA | -464.52 | |||||
EV-to-Revenue | 4.76 | |||||
EV-to-Forward-Revenue | 4.4 | |||||
EV-to-FCF | -11.28 | |||||
Price-to-GF-Value | 0.58 | |||||
| Price-to-Net-Current-Asset-Value | 12.24 | |||||
Earnings Yield (Greenblatt) % | -3.42 | |||||
FCF Yield % | -7.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sedana Medical AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 17.939 | ||
| EPS (TTM) (€) | -0.033 | ||
| Beta | 1.7602 | ||
| 3-Year Sharpe Ratio | -0.11 | ||
| 3-Year Sortino Ratio | -0.16 | ||
| Volatility % | 66.18 | ||
| 14-Day RSI | 71.99 | ||
| 14-Day ATR (€) | 0.017664 | ||
| 20-Day SMA (€) | 0.75575 | ||
| 12-1 Month Momentum % | -50.65 | ||
| 52-Week Range (€) | 0.668 - 1.524 | ||
| Shares Outstanding (Mil) | 99.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sedana Medical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sedana Medical AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-22 | In 81 days | ||
| Third quarter earnings results for 2026 | 2026-10-22 | In 81 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-17 13:30 | 0.75 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-07-17 | 0.75 (+0.00%) | ||
| General meeting for 2026 | 2026-05-27 16:00 | 0.86 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-04-23 13:30 | 0.92 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-23 07:00 | 0.92 (+0.00%) | ||
| Annual report for 2025 | 2026-04-15 | 0.82 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-12 13:30 | 0.90 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-12 07:00 | 0.90 (+0.00%) |
Show
Entries
Sedana Medical AB Frequently Asked Questions
What is Sedana Medical AB(FRA:7D2A)'s stock price today?
The current price of FRA:7D2A is €0.86. The 52 week high of FRA:7D2A is €1.52 and 52 week low is €0.67.
When is next earnings date of Sedana Medical AB(FRA:7D2A)?
The next earnings date of Sedana Medical AB(FRA:7D2A) is .
Does Sedana Medical AB(FRA:7D2A) pay dividends? If so, how much?
Sedana Medical AB(FRA:7D2A) does not pay dividend.
Press Release
Articles on Sedana Medical AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers